I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
minulý týden
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
minulý týden
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
před 2 týdny
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
před 2 týdny
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
před 3 měsíci
This too (and yh I DO wish I did this in CFD lol)
GGGGM
před 3 měsíci
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
před 3 měsíci
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
před 3 měsíci
What do we think
At a loss now, watching a bit
GGGGM
před 3 měsíci
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
před 3 měsíci
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
před 3 měsíci
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
před 3 měsíci
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Tato stránka může obsahovat obsah vytvořený komunitou, za který společnost Trading 212 nenese odpovědnost. Vždy prováděj vlastní průzkum. Trading 212 poskytuje pouze exekuční služby a nenabízí investiční poradenství ani správu portfolia.
Vyber si sám z předpřipravených Pie, nebo si vytvoř vlastní výběrem z tisíců akcií a ETF
Zjistit více
Zjistit více
Pustit video
Vlastni i ty nejdražší akcie jako Google, Amazon a Apple
Pustit video
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisabon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisabon
Zobrazit všechny obchodní nástroje
Podpora 24/7
Průměrná doba odezvy 29 sekund
Začni budovat své bohatství teď
Přidej se k více než 5 milionům klientů
Získat aplikaci
Otevřít účet
Získej mobilní aplikaci
Všechny prezentované statistiky jsou globální. Počet klientů představuje financované účty.
Skvělé
Hodnoceno 4,6 / 5 založeno na 108 764 hodnoceních
Trustpilot
Hodnoceno 4,6 / 5 založeno na 108 764 hodnoceních
Trustpilot
Pozvaní
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Pozvaní
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Pozvaní
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Pozvaní
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Pozvaní
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Pozvaní
How you rate the app
This app is so easy to use and safe really love it.
Pozvaní
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Pozvaní
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Pozvaní
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Pozvaní
Very good and informative always stay…
Very good and informative always stay on track with your investments
Pozvaní
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Pozvaní
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Pozvaní
Very easy app to register and use
Very easy app to register and use! Really pleased.
Pozvaní
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Pozvaní
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Pozvaní
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Pozvaní
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Pozvaní
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Pozvaní
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Pozvaní
Reliable
Reliable, Secure. Using it for past 3 years
Zobrazí se některé z pozitivních recenzí našich klientů
Naše ocenění
Často kladené otázky
Jaká je cena akcie Capricor Therapeutics?
Aktuální cena Capricor Therapeutics je 7,59 $.
Jaké je 52týdenní maximum Capricor Therapeutics?
52týdenní maximum pro Capricor Therapeutics je 40,37 $.
Jaké je 52týdenní minimum Capricor Therapeutics?
52týdenní minimum pro Capricor Therapeutics je 2,96 $.
Jaký je týdenní výkon Capricor Therapeutics?
Za poslední týden se cena Capricor Therapeutics změnila o -20,36 %.
Jaký je měsíční výkon Capricor Therapeutics?
Za poslední měsíc se cena Capricor Therapeutics změnila o 14,14 %.
Jaký je 3měsíční výkon Capricor Therapeutics?
Za poslední tři měsíce se cena Capricor Therapeutics změnila o -4,89 %.
Jaký je 6měsíční výkon Capricor Therapeutics?
Za posledních šest měsíců se cena Capricor Therapeutics změnila o -71,81 %.
Jaký je roční výkon Capricor Therapeutics?
Za poslední rok se cena Capricor Therapeutics změnila o 31,54 %.